VRAX   $2.5917  -4.01% Market Open

Virax Biolabs Group Ltd
Total Cash 3.67M
totalCashPerShare 1.425
EBITDA -6.05M
Total Debt 224.30K
quickRatio 23.005
currentRatio 25.942
Total Revenue 156.42K
debtToEquity 4.365
Revenue/Share 0.078
ROA -0.49898
ROE -0.9598
grossProfits
freeCashflow -4.99M
operatingCashflow -6.25M
earningsGrowth
revenueGrowth 27.522
grossMargins 0.32342997
ebitdaMargins 0.0
operatingMargins -42.54122
profitMargins 0.0
enterpriseValue 3.00M
forwardPE
floatShares 2.40M
sharesOutstanding 4.34M
sharesShort 632.43K
sharesShortPriorMonth 18.87K
dateShortInterest
sharesPercentSharesOut 0.15%
heldPercentInsiders 0.07%
heldPercentInstitutions 0.02%
Short Ratio help_outline 0.06%
shortPercentOfFloat 0.16%
impliedSharesOutstanding
bookValue 2.085
Price To Book help_outline 1.36
earningsQuarterlyGrowth
netIncomeToCommon -6.73M
trailingEps -3.36%
forwardEps -1.90%
enterpriseToEbitda -0.49
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 8
lastUpdated Sept. 17, 2024, 1:44 a.m.